Quinolone antibacterial agents have adverse effects on the musculoskeletal system in humans, consisting mainly of myalgia and arthralgia, and additionally of tendon disorders and rhabdomyolysis. The present study was conducted to examine the toxic effects of quinolones on the musculoskeletal system in juvenile rats using light microscopy, 5-bromo-2'-deoxyuridine (BrdU) immunohistochemistry and electron microscopy. Single oral administration of 900 mg/kg pefloxacin (PFLX) or levofloxacin (LVFX) was found to induce lesions in the muscle + fascia, tendon + sheath, and synovial membrane, in addition to articular cartilage in the fore- and hindlimbs. Articular cartilage lesions were not necessarily associated with changes in the muscle, tendon, and synovial membrane, or the reverse. Among all lesions, the ankle and elbow showed the highest incidence and severity. Changes were more severe in the PFLX than in the LVFX group. Lesions in the muscle + fascia, tendon + sheath, and synovial membrane were similar and characterized by edema and increased number of mononuclear cells, many of which were positively stained with BrdU, as well as vascular endothelial cells in the Achilles tendon sheath and synovial membrane in the ankle. Electron microscopic examination revealed an increased number of fibroblasts and macrophages and collagen deposition in the matrix of the synovial membrane and tendon sheath. Capillary endothelial cells were hypertrophied, increased in number, and stratified. These results suggest that quinolones have toxic potentials in the muscle, tendon, and synovial membrane in addition to articular cartilage, and that local vascular hyperpermeability may contribute to the development of these lesions.
Bailey RR, Kirk JA, and Peddie BA (1983). Norfloxacin-induced rheumatic disease. N. Z. Med. J. 96: 590.
2.
Burkhardt JE , Hill MA, Lamar CH, Smith GN, and Carlton WW (1993). Effects of difloxacin on the metabolism of glycosaminoglycans and collagen in organ cultures of articular cartilage. Fundam. Appl. Toxicol . 20: 257-263.
3.
Christ W., Lehnert T., and Ulbrich B. (1988). Specific toxicologic aspects of the quinolones . Rev. Infect. Dis. 10: S141-S146.
4.
De-Petro G., Barlati S., Vartio T., and Vaheri A. (1983). Transformation-enhancing activity in plasma of tumour patients: Relationship with fibronectic fragments. Int. J. Cancer31: 157-162.
5.
Förster C., Kociok K., Shakibaei M., Merker H.-J, Vormann J., Günther T., and Stahlmann R. (1996). Integrins on joint cartilage chondrocytes and alterations by ofloxacin or magnesium deficiency in immature rats. Arch. Toxicol. 70: 261-270.
6.
Gough A., Barsoum NJ, Mitchell L., McGuire EJ, and Iglesia FA (1979). Juvenile canine drug-induced arthropathy: Clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol. Appl. Pharmacol. 51: 177-187.
7.
Gough A., Johnson R., Campbell E., Hall L., Tylor J., Carpenter A., Black W., Basrur PK, Baragi VM, Siglar R., and Metz A. (1996). Quinolone arthropathy in immature rabbits treated with the fluoroquinolone, PD 117596. Exp. Toxic. & Pathol . 48: 225-232.
8.
Gough AW, Kasali OB, Sigler RE, and Baragi V. (1992). Quinolone arthropathy-Acute toxicity to immature articular cartilage. Toxicol. Pathol. 20: 436-449.
9.
Hellewell PG and Williams TJ (1987). Interaction between eicosanoids and other mediators of inflammation. In: Eicosanoids in Inflammatory Conditions of the Lung, Skin and Joints, Advance Eicosanoid Research, M Church and C Robinson (ed). MTP Press, Lancester, pp. 43-65.
10.
Higgs GA, Moncada S., and Vane JR (1984). Eicosanoids and inflammation. Am. Clin. Res. 16: 287-299.
11.
Japanese Ministry of Health and Welfare (1994). Information on adverse reactions to drugs. No. 128. J. Jpn. Pharm. Assoc.46: 67-70.
12.
Jorgensen C. , Anaya JM, Didry C., Canovas F., Serre I., Baldet P., Ribard P., Kahn MF, and Sany J. (1991). Arthropathies et tendinopathie achilléenne induites par la péfloxacine. A propos d'une observation. Rev. Rhum. 58: 623-625.
13.
Kashida Y. and Kato M. (1997). Possible involvement of nitric oxide in the quinolone-induced tendon lesions in rats. Drugs Exp. Clin. Res. (in press).
14.
Kato M. and Onodera T. (1988). Morphological investigation of cavity formation in articular cartilage induced by ofloxacin in rats. Fundam. Appl. Toxicol. 11: 110-119.
15.
Kato M., Takada S., Kashida Y., and Nomura M. (1995). Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats. Toxicol. Pathol. 23: 385-392.
16.
Linseman DA , Hampton LA, and Branstetter DG (1995). Quinolone-induced arthropathy in the neonatal mouse: Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin . Fundam. Appl. Toxicol. 28: 59-64.
17.
Majno G., Palade GE, and Schoefl GI (1961). Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: A topographic study. J. Biophys. Biochem. Cytol. 11: 607-625.
18.
Majno G., Shea SM, and Leventhal M. (1969). Endothelial contraction induced by histamine-type mediators. An electron microscopic study. J. Cell Biol. 42: 647-672.
19.
Mark RM, Roche W.-E, Czerniecki M., Penney R., and Nelson DS (1986). Mast cell granules cause proliferation of human microvascular endothelial cells. Lab. Invest. 55: 289-294.
20.
McEwan SR and Davey PG (1988). Ciprofloxacin and tenosynovitis . Lancet15: 900.
21.
Meyboom RHB , Olsson S., Knol A., Dekens-Konter JAM, and De Koning GHP (1994). Achilles tendinitis induced by pefloxacin and other fluoroquinolone derivatives . Pharmacoepidemiol. Drug Saf. 3: 185-189.
22.
Mori H., Tanaka H., Kawada K., Nagai H., and Koda A. (1995). Suppressive effects of tranilast on pulmonary fibrosis and activation of alveolar macrophages in mice treated with bleomycin: Role of alveolar macrophages in mice treated with bleomycin: Role of alveolar macrophages in the fibrosis. Jpn. J. Pharmacol. 67: 279-289.
23.
Ribard P., Audisio F., Kahn M.-F, De Bandt M., Jorgensen C., Hayam G., Meyer O., and Palazzo E. (1992). Seven Achilles tendinitis including 3 complicated by rupture during fluoroquinolone therapy. J. Rheumatol. 19: 1479-1481.
24.
Royer RJ, Pierfitte C., and Netter P. (1994). Features of tendon disorders with fluoroquinolones . Therapie49: 75-76.
25.
Samuelsson B. (1983). Leukotriens: Mediators of immediate hypersensitivity reactions and inflammation. Science220: 568-575.
26.
Sharpnack D. , Mastin JP, Childress CP, and Henningsen GM (1994). Quinolone arthropathy in juvenile New Zealand White rabbits. Lab. Anim. Sci. 44: 436-442.
27.
Stahlmann R. , Förster C., Shakibaei M., Vormann J., Günther T., and Merker H.-J (1995). Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob. Agents Chemother. 39: 2013-2018.
28.
Stahlmann R. and Lode H. (1988). Safety overview: Toxicity, adverse effects and drug interactions. In: The Quinolones, VT Andriole (ed). Academic Press, London, pp. 201-233.
29.
Stahlmann R. , Merker HJ, Hinz N., Chahoud I., Webb J., Heger W., and Neubert D. (1990). Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch. Toxicol. 64: 193-204.
30.
Takada S., Kato M., and Takayama S. (1994). Comparison of lesions induced by intra-articular injections of quinolones and compounds damaging cartilage components in rat femoral condyle. J. Toxicol. Environ. Health42: 73-88.
31.
Takasuna K.Kasai Y., Usui C., Takahashi M.Hirohashi M.Tamura K., and Takayama S. (1992). General pharmacology of the new quiolone antibacterial agent levofloxacin . Arzneimittelforschung42: 408-418.
32.
Tatsumi H., Senda H., Yatera S., Takemoto Y.Yamayoshi M. and Ohnishi K. (1978). Toxicological studies on pipemidic acid: Effect on diarthrodial joints of experimental animals. J. Toxicol. Sci. 3: 357-367.
33.
Tin Lee W. and Collins JF (1992). Ciprofloxacin associated bilateral achilles tendon rupture. Aust. N. Z. J. Med. 22: 500.
34.
Vartio T., Vaheri A., De-Petro G., and Barlati S. (1983). Fibronectin and its proteolytic fragments. Potential as cancer markers. Invasion Metastasis. 3: 125-138.
35.
Yi ES and Ulich TR (1992). Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules . Am. J. Pathol. 140: 659-663.
36.
Yoshida M., Takayama S., and Kato M. (1994). Effect of levfloxacin and ciprofloxacin injection on permeability of the tail vein in mice and skin microvasculature in rats . Int. J. Tissue React. 16: 105-112.
37.
Zabraniecki L., Negrier I., Vergne P., Arnaud M., Bonnet C., Bertin P., and Treves R. (1996). Fluoroquinolone induced tendinopathy: Report of 6 cases. J. Rheumatol. 23: 516-520.
